These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31806078)

  • 21. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
    Igishi T; Shigeoka Y; Yasuda K; Suyama H; Katayama S; Sugitani A; Matsumoto S; Yamamoto M; Ueda Y; Takeda K; Sumikawa T; Sako T; Kodani M; Hitsuda Y; Shimizu E
    J Thorac Oncol; 2009 Mar; 4(3):376-82. PubMed ID: 19190514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.
    Martoni A; Guaraldi M; Piana E; Strocchi E; Petralia A; Busutti L; Preti P; Robustelli G; Raimondi M; Ferrara G; Palomba G; Lelli G; Picece V; Recaldin E; Caffo O; Ambrosini G; Sarobba G; Farris A; Pannuti F
    Lung Cancer; 1998 Oct; 22(1):31-8. PubMed ID: 9869105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.
    Devlin JG; Langer CJ
    Clin Lung Cancer; 2007 Mar; 8(5):319-26. PubMed ID: 17562231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
    Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
    Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.
    Camerini A; Morabito A; Montanino A; Bernabé R; Grossi F; Ramlau R; Ciuleanu TE; Ceresoli GL; Pasello G; de Marinis F; Bosch-Barrera J; Laundreau P; Gautier S; Ta Thanh Minh C; Kowalski D
    ESMO Open; 2021 Apr; 6(2):100051. PubMed ID: 33611164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M; Guérin JC; Thomas P; Poirier R; Carles P; Robinet G; Kleisbauer JP; Paillotin D; Vergnenègre A; Balmes P; Touron D; Grivaux M; Pham E
    Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.
    Camerini A; Valsuani C; Mazzoni F; Siclari O; Puccetti C; Donati S; Rondini M; Tartarelli G; Puccinelli P; Di Costanzo F; Amoroso D
    Ann Oncol; 2010 Jun; 21(6):1290-1295. PubMed ID: 19914959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
    Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study.
    Gridelli C; Cigolari S; Maiorino A; Ianniello GP; Brancaccio L; Rossi A; De Cataldis G; Pedicini T; Maiorino L; Barletta E; Di Lanno M; Bilancia D; Crispino C; Barzelloni ML; Masullo P; D'Aniello R; Manzione L
    Lung Cancer; 2000 Jun; 28(3):237-44. PubMed ID: 10812192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer.
    Farhat FS; Ghosn MG; Kattan JG
    Cancer Chemother Pharmacol; 2015 Aug; 76(2):235-42. PubMed ID: 26024554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC.
    Mencoboni M; Filiberti RA; Taveggia P; Del Corso L; Del Conte A; Covesnon MG; Puccetti C; Donati S; Auriati L; Amoroso D; Camerini A
    Anticancer Res; 2017 Jun; 37(6):3189-3194. PubMed ID: 28551663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy with vinorelbine plus split-dose cisplatin may be an option in inoperable stage III non-small cell lung cancer: a single-center experience.
    Mertsoylu H; Köse F; Sümbül AT; Sedef AM; Doğan Ö; Besen AA; Parlak C; Fındıkçıoğlu A; Muallaoğlu S; Sezer A; Sakallı H; Özyılkan Ö
    Med Sci Monit; 2015 Mar; 21():661-6. PubMed ID: 25731741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
    Douillard JY; Gervais R; Dabouis G; Le Groumellec A; D'Arlhac M; Spaeth D; Coudert B; Caillaud D; Monnier A; Clary C; Maury B; Mornet M; Rivière A; Clouet P; Couteau C
    Ann Oncol; 2005 Jan; 16(1):81-9. PubMed ID: 15598943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.
    LeCaer H; Delhoume JY; Thomas PA; Berard H; Paillotin D; Barriere JR; Gimenez C; Vergnenegre A; Muller P; Auquier P; Perol M
    Clin Lung Cancer; 2005 Sep; 7(2):114-20. PubMed ID: 16179098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.
    Rossi D; Catalano V; Alessandroni P; Fedeli A; Fedeli SL; Giordani P; Baldelli AM; Casadei V; Ceccolini M; Ugolini M; Dennetta D; Catalano G
    Clin Lung Cancer; 2007 May; 8(6):382-5. PubMed ID: 17562239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
    Belani CP; Fossella F
    Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
    Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients.
    Veronesi A; Crivellari D; Magri MD; Cartei G; Mansutti M; Foladore S; Monfardini S
    Eur J Cancer; 1996 Sep; 32A(10):1809-11. PubMed ID: 8983294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
    Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL
    Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.
    Wibmer T; Berghmans T; Kropf-Sanchen C; Lafitte JJ; Rüdiger S; Paesmans M; Blanta I; Scherpereel A; Stoiber KM; Rottbauer W; Sculier JP; Schumann C
    Lung; 2013 Jun; 191(3):271-80. PubMed ID: 23564228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.